Product How it works Pricing Blog FAQ About Contact
Xylem

Xylem (NYSE: XYL) net income

Xylem reported a net profit of $957.0m for fiscal 2025, 7.5% more than in fiscal 2024 ($890.0m). Its net margin was 10.6%. Earnings per share were $3.93.

Net income, in millions of US dollars260.02016331.02017549.02018401.02019254.02020427.02021355.02022609.02023890.02024957.02025

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$957.0m+7.5%10.6%$3.93
2024$890.0m+46.1%10.4%$3.67
2023$609.0m+71.5%8.3%$2.81
2022$355.0m−16.9%6.4%$1.97
2021$427.0m+68.1%8.2%$2.37
2020$254.0m−36.7%5.2%$1.41
2019$401.0m−27.0%7.6%$2.23
2018$549.0m+65.9%10.5%$3.05
2017$331.0m+27.3%7.0%$1.84
2016$260.0m—6.9%$1.45

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the net income of Xylem

How much did Xylem earn in fiscal 2025?
Xylem reported a net profit of $957.0m for fiscal 2025. In fiscal 2024 it reported a net profit of $890.0m.
What are the earnings per share of Xylem?
They were $3.93 in fiscal 2025, compared with $3.67 in fiscal 2024.
What is the net margin of Xylem?
In fiscal 2025 its net profit was 10.6% of its revenue.
What was the most profitable year for Xylem?
Of its last 10 fiscal years, fiscal 2025, with $957.0m.
Where do the figures for Xylem come from?
From the annual report (Form 10-K) that Xylem files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Xylem files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Xylem: the Xylem page · annual accounts · revenue · dividends paid · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.